The Federation of Clinical Immunology Societies is a key forum where opinion leaders come together to chart the path to the next major breakthrough in disease therapy.
Through FOCIS, researchers and clinicians share knowledge across traditional disease borders, and identify commonalities between treatments and therapies that are life-changing for those impacted by immune-mediated diseases.
Jeff Bluestone, PhD
FOCIS Past President, 2018-2020
Chief Executive Officer and President, Sonoma Biotherapeutics
Initially established as a cross-disciplinary meeting, FOCIS held its first Annual Meeting in 2001. After two successful consecutive meetings, FOCIS incorporated as a 501(c)3 organization in 2003. Today, FOCIS has 66 Member Societies, representing roughly 65,000 clinician scientists.
66
Member Societies
65,000
Clinician Scientists Represented
80
FOCIS Centers of Excellence
David Hafler, MD, FANA
Chair, Department of Neurology, Yale University
Neurologist-in-Chief, Yale New Haven Hospital
The FOCIS Annual Meeting and FOCISed courses educate clinicians, researchers, and trainees in the broad discipline of clinical immunology. FOCIS is the world’s leader in immunology education and in training future generations of clinical immunologists.
C. Garrison Fathman, MD
Professor of Medicine (Immunology and Rheumatology), Emeritus, Stanford University